629 related articles for article (PubMed ID: 10650129)
1. Fos induction in selective hypothalamic neuroendocrine and medullary nuclei by intravenous injection of urocortin and corticotropin-releasing factor in rats.
Wang L; Martínez V; Vale W; Taché Y
Brain Res; 2000 Feb; 855(1):47-57. PubMed ID: 10650129
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal corticotropin-releasing factor and urocortin induce Fos expression in brain and spinal autonomic nuclei and long lasting stimulation of colonic motility in rats.
Maillot C; Wang L; Million M; Taché Y
Brain Res; 2003 Jun; 974(1-2):70-81. PubMed ID: 12742625
[TBL] [Abstract][Full Text] [Related]
3. C-fos mRNA pattern and corticotropin-releasing factor neuronal activity throughout the brain of rats injected centrally with a prostaglandin of E2 type.
Lacroix S; Valliéres L; Rivest S
J Neuroimmunol; 1996 Nov; 70(2):163-79. PubMed ID: 8898725
[TBL] [Abstract][Full Text] [Related]
4. Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat.
Mönnikes H; Lauer G; Arnold R
Brain Res; 1997 Oct; 770(1-2):277-88. PubMed ID: 9372230
[TBL] [Abstract][Full Text] [Related]
5. Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus.
Laflamme N; Bovetto S; Richard D; Rivest S
Br J Pharmacol; 1996 Mar; 117(6):1021-34. PubMed ID: 8882592
[TBL] [Abstract][Full Text] [Related]
6. Intracerebroventricular CRF inhibits cold restraint-induced c-fos expression in the dorsal motor nucleus of the vagus and gastric erosions in rats.
Wang L; Cardin S; Martínez V; Taché Y
Brain Res; 1996 Oct; 736(1-2):44-53. PubMed ID: 8930307
[TBL] [Abstract][Full Text] [Related]
7. Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons.
Spiga F; Lightman SL; Shekhar A; Lowry CA
Neuroscience; 2006; 138(4):1265-76. PubMed ID: 16488545
[TBL] [Abstract][Full Text] [Related]
8. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
Larsen PJ; Tang-Christensen M; Jessop DS
Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
[TBL] [Abstract][Full Text] [Related]
9. Fourth ventricular CART peptide induces c-fos in the area postrema and nucleus of the solitary tract via a CRF-receptor dependent mechanism.
Smedh U; Scott KA; Moran TH
Neurosci Lett; 2015 Nov; 609():124-8. PubMed ID: 26475505
[TBL] [Abstract][Full Text] [Related]
10. Involvement of serotonergic pathways in mediating the neuronal activity and genetic transcription of neuroendocrine corticotropin-releasing factor in the brain of systemically endotoxin-challenged rats.
Laflamme N; Feuvrier E; Richard D; Rivest S
Neuroscience; 1999 Jan; 88(1):223-40. PubMed ID: 10051203
[TBL] [Abstract][Full Text] [Related]
11. Intracerebroventricular administration of corticotropin-releasing factor induces c-fos mRNA expression in brain regions related to stress responses: comparison with pattern of c-fos mRNA induction after stress.
Imaki T; Shibasaki T; Hotta M; Demura H
Brain Res; 1993 Jul; 616(1-2):114-25. PubMed ID: 8358602
[TBL] [Abstract][Full Text] [Related]
12. Abdominal surgery activates nesfatin-1 immunoreactive brain nuclei in rats.
Stengel A; Goebel M; Wang L; Taché Y
Peptides; 2010 Feb; 31(2):263-70. PubMed ID: 19944727
[TBL] [Abstract][Full Text] [Related]
13. Differential induction of c-Fos immunoreactivity in hypothalamus and brain stem nuclei following central and peripheral administration of endotoxin.
Wan W; Janz L; Vriend CY; Sorensen CM; Greenberg AH; Nance DM
Brain Res Bull; 1993; 32(6):581-7. PubMed ID: 8221156
[TBL] [Abstract][Full Text] [Related]
14. Expression of corticotropin releasing factor (CRF), urocortin and CRF type 1 receptors in hypothalamic-hypophyseal systems under osmotic stimulation.
Imaki T; Katsumata H; Miyata M; Naruse M; Imaki J; Minami S
J Neuroendocrinol; 2001 Apr; 13(4):328-38. PubMed ID: 11264720
[TBL] [Abstract][Full Text] [Related]
15. Corticotropin-releasing factor and systemic capsaicin-sensitive afferents are involved in abdominal surgery-induced Fos expression in the paraventricular nucleus of the hypothalamus.
Bonaz B; Taché Y
Brain Res; 1997 Feb; 748(1-2):12-20. PubMed ID: 9067440
[TBL] [Abstract][Full Text] [Related]
16. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing factor mediates the antinociceptive action of nitrous oxide in rats.
Sawamura S; Obara M; Takeda K; Maze M; Hanaoka K
Anesthesiology; 2003 Sep; 99(3):708-15. PubMed ID: 12960557
[TBL] [Abstract][Full Text] [Related]
18. Chronic psychosocial stress affects corticotropin-releasing factor in the paraventricular nucleus and central extended amygdala as well as urocortin 1 in the non-preganglionic Edinger-Westphal nucleus of the tree shrew.
Kozicz T; Bordewin LA; Czéh B; Fuchs E; Roubos EW
Psychoneuroendocrinology; 2008 Jul; 33(6):741-54. PubMed ID: 18394812
[TBL] [Abstract][Full Text] [Related]
19. Intracerebroventricular administration of corticotropin-releasing factor antagonist attenuates c-fos mRNA expression in the paraventricular nucleus after stress.
Imaki T; Shibasaki T; Wang XQ; Demura H
Neuroendocrinology; 1995 Apr; 61(4):445-52. PubMed ID: 7783858
[TBL] [Abstract][Full Text] [Related]
20. Patterns of neuronal activation in the rat brain and spinal cord in response to increasing durations of restraint stress.
Crane JW; French KR; Buller KM
Stress; 2005 Sep; 8(3):199-211. PubMed ID: 16236624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
